Partnering: Micar Innovation (Micar21) aims to progress its programmes to IND-enabling studies, but to seek a partner or investment to take further forward. Currently some of our programmes is available for outlicensing and we are happy to discuss strategic collaborations regarding our epigenetics work. Contact us for more information.

The speed and breadth of our discovery engine is unprecedented. Our technology enables us to identify hits within days of a signed contract in some cases. Micar21 understands that strong collaborations are the key to driving scientific progress. We have fostered many relationships with partners who share our goals of bringing innovative Drug Discovery faster technology to the world.

UNM School of Medicine | The University of New Mexico

To learn more about partnership opportunities, please email us